SPOTLIGHT -
The 'golden gate' to the Golden State has much to offer explorers, sightseers, history buffs?and everyone else
Real-world data support safety, efficacy of Aquablation for BPH-related LUTS
"The results showed the contemporary Aquablation procedural safety in Japanese men is exceptional in a broad range of prostate sizes along with significant symptom reduction," says Nobuyuki Hinata, MD.
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Licensing agreement reached for contrast agent for use in patients with prostate cancer
A late phase 3 trial evaluating the agent is underway at several clinics in Europe.
Dr. Murphy on increasing diversity in cancer clinical trials
In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
First patient dosed with TLX250-CDx for ccRCC in Australia
The first patient was treated with TLX250-CDx at the Olivia Newton-John Cancer Wellness Centre at Austin Health in Melbourne, Australia,
The emotional toll of surgical complications on urologic surgeons
"It is important as a field that we recognize the potential emotional impact of surgical adverse events," writes Amy N. Luckenbaugh, MD.